Kejin Biotechnology
About:
Kejin Biotechnology develops high-end laboratory consumables and underlying novel materials that are monopolized by imports.
Top Investors: Addor Capital, Industrial Securities Capital, Sinopharm-CICC
Description:
Kejin Biotechnology performs research and development of high-end laboratory consumables and membrane products for liquid treatment, molecular biology, cell preservation, and culture, which are based on innovative materials monopolized by imports.
Total Funding Amount:
100M CNY
Headquarters Location:
Zhangjiang, Shanghai, China
Founded Date:
Founders:
Number of Employees:
Last Funding Date:
2023-05-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai